Kolkata, Sep 20 (UNI) Leading industry bodies representing medical technology sector

today came together at MTaIMedTekon 2018 to discuss ways to strengthen healthcare

delivery under Ayushman Bharat scheme, a government programme to enable the bottom

40 per cent of India’s population access healthcare for free.

Representatives of Medical Technology Association of India (MTaI), Advance Medical

Technology Association (AdvaMed), AmCham Medical Devices Committee,

Confederation of Indian Industries (CII), Healthcare Federation of India (NATHEALTH)

and Federation of Indian Chambers of Commerce and Industries (FICCI), underscoring

their solidarity, huddled up with government officials, doctors, investors and patients’

groups to chalk out a roadmap for the industry to contribute effectively to the world’s

largest healthcare reform programme.

Starting September 25, the government plans to provide health insurance to 10 crore

families and also strengthen the network of primary health centers in the country. Most

secondary and tertiary treatments will be covered under the scheme.

As per statistics, health insurance has spread only to 27 per cent of the population-the

cover being sparse-and more than 80 per cent of healthcare expenditure is incurred by

individuals from their own pockets.

“We admire the vision of inclusion behind Ayushman Bharat and the programme’s

massive scale. It has the ability to stimulate the economy due to its impact on the health

of the labor force as well as provide a new ecosystem in healthcare business which can

sprout a thousand new ladders of commercial success,” MTaI Chairman Pavan Choudary

said.

For the scheme, the government has recommended maximum allowable costing for

1363 health procedures.

Probir Das, Senior Vice President, Healthcare Federation of India (NATHEALTH),

said, “The cost structure still needs work. While for many procedures the cost may be

optimum, for several, it may require a re-think. The ideal way to resolve this problem will

be to keep the cost of medical devices outside the procedure costs. Also, given the fact

that international MedTech companies use their global network to train physicians and

develop modern therapies in India, they should be considered as a vital pillar for

consultation and programme development.”

BadhriIyengar, Chairman of FICCI’s Medical Devices & Equipment Committee, said,

“Medical devices and diagnostic services are very important in health treatments. By

the virtue of this, we feel that the medical technology industry is an important stakeholder

for Ayushman Bharat. We are committed to contributing in letter and spirit to the

successful implementation of the pathbreaking scheme. Today’s deliberations have been

important in paving the way for this.”

Madan Krishnan, Chairman, AdvaMed, said, “the next stage of today’s constructive

dialogue is industry-government dialogue to enhance impact and success of the

programme. MedTech industry can actively partner with the government and providers

to transform healthcare in India by structuring effective patient care pathways along

with outcome based models.”

Diwaker Rana, Co-Chairman MTaIMedtekon said, “A comprehensive view of the

healthcare industry should be taken to make it rewarding for all stakeholders. This will

poise it for success.”

“The Ayushman Bharat Scheme will significantly bring down the out of pocket

healthcare expenses and have an indirect impact on individual wealth which will lead

to economic growth of the nation. The other longer term and most important impact

of the scheme will be the data repository through AB-NHPM, it will facilitate research

and evidence-based decision making in future.” added Himanshu Baid, Chairman of

Medical technology Division, CII.

The summit was inaugurated by Dr. Vinod K. Paul, Member, NITIAayog.

In his speech, Dr. Paul said, “Ayushman Bharat is based on three pillars: Primary

Health, Diagnosis and Health Insurance. The scheme at present takes care of

lowest two quintiles of our population. It is an integrated healthcare scheme where

we have integrated the public and private sectors and given patients the power to

decide where they want to access the healthcare services from. To me, it is an

anti-poverty measure which prevents people from falling into poverty due to

healthcare requirements. I believe if we save a healthy life for a year, we can add

1.5 per cent to the GDP.”

Dr. Paul urged the international fraternity to suggest how they can contribute to

Ayushman Bharat scheme. “The international fraternity can help us strengthen the

scheme going forward. They have a strong R&D, can bring investments for Make

in India, set up health and wellness centres through their CSR centers and train

healthcare professionals. I would like to ask the fraternity to come up with ideas

on how they can contribute to the scheme,” he added.

During the summit, MTaI unveiled a theme paper entitled ‘MedTech – The Keystone

for Ayushman Bharat’. The paper presents Ayushman Bharat scheme in summary

and points out the concerns of stakeholders which need to be dovetailed to ensure

success. The theme paper also brings out the possible solution to these concerns.

“For the success of the Ayushman Bharat programme, it will require the coordinated

action of all stakeholders in the complex healthcare industry including health insurers

and TPAs, providers, the pharmaceutical industry, the medical device & diagnostic

industry Ayushman Bharat has the potential to transform the perception of the Indian

public towards government healthcare schemes. It will be no small feat to achieve

the core objectives that it has set for itself and if the scheme is implemented in a

methodical, systematic and well researched manner, the Healthcare landscape shall

truly be transformed.” the paper states.

UNI BM